Shilanski & Associates, Inc. current holdings: Foreign ADRs
Shilanski & Associates, Inc. reported $0.00 billion in depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), 1 positions, in its Form 13F for the quarter ended 2025-09-30; the largest are ASCENDIS PHARMA A/S.
- ASCENDIS PHARMA A/S: Country of operation —; Class SPONSORED ADR; Shares 1,304; Value $259,248.
Form 13F-HR as filed (SEC CIK 1722084): quarter ended 2025-09-30, filed 2025-10-20. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||